Rani Therapeutics Inc. (RANI)
NASDAQ: RANI
· Real-Time Price · USD
0.51
0.01 (0.99%)
At close: Oct 03, 2025, 3:59 PM
0.51
0.40%
Pre-market: Oct 06, 2025, 08:14 AM EDT
0.99% (1D)
| Bid | 0.49 |
| Market Cap | 36.86M |
| Revenue (ttm) | 1.2M |
| Net Income (ttm) | -29.69M |
| EPS (ttm) | -0.92 |
| PE Ratio (ttm) | -0.55 |
| Forward PE | -1.23 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.55 |
| Volume | 274,828 |
| Avg. Volume (20D) | 1,832,514 |
| Open | 0.52 |
| Previous Close | 0.51 |
| Day's Range | 0.50 - 0.53 |
| 52-Week Range | 0.39 - 3.75 |
| Beta | -0.01 |
| Ex-Dividend Date | n/a |
About RANI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RANI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RANI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-38.92%
Rani Therapeutics Holdings shares are trading lowe...
Unlock content with
Pro Subscription
2 months ago
+8.45%
RANI stock has given up its prior gain. Rani Therapeutics shares were trading higher after the company announced it has unveiled preclinical data at ENDO 2025 for the RaniPill capsule.
